SCHEMBL32688442

SCHEMBL32688442

N#Cc1c(S)[nH]c(=O)c(C#N)c1-c1ccccc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.52
▸ PDE9A O76083 1/20 0.51
▸ PIM1 P11309 3/20 0.49
▸ BIRC5 O15392 2/20 0.49
▸ IDO1 P14902 1/20 0.48
▸ HTT P42858 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ HPGD P15428 4/20 0.44
▸ GAA P10253 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ XDH P47989 1/20 0.43
▸ HSD11B1 P28845 1/20 0.43
▸ GLA P06280 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ GALR3 O60755 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688480 0.89 KDM4E (0.51) ATMPDE9APIM1BIRC5IDO1
SCHEMBL32688266 0.86 ALDH1A1 (0.48) ATMPDE9APIM1BIRC5HTT
SCHEMBL32687999 0.86 PIM1 (0.52) PIM1HTTALDH1A1KDM4EHPGD
SCHEMBL32688154 0.85 PDE9A (0.57) ATMPDE9AIDO1ALDH1A1KDM4E
SCHEMBL32688430 0.81 PDE9A (0.50) ATMPDE9APIM1BIRC5IDO1
SCHEMBL32688284 0.81 PIM1 (0.47) ATMPDE9APIM1IDO1ALDH1A1
SCHEMBL20339898 0.78 PDE9A (0.49) ATMPDE9AIDO1ALDH1A1KDM4E
SCHEMBL20339228 0.78 KDM4E (0.49) ATMPDE9AIDO1HTTALDH1A1
SCHEMBL12681420 0.77 ALDH1A1 (0.47) ATMPIM1BIRC5ALDH1A1KDM4E
SCHEMBL20339404 0.75 ATM (0.58) ATMPIM1BIRC5HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ATM 1884/4885PDE9A 1443/4885PIM1 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback